本页面由Tiger Trade Technology Pte. Ltd.提供服务

Arcutis Biotherapeutics Inc.

23.56
+2.2310.45%
盘后23.560.00000.00%19:57 EDT
成交量:206.26万
成交额:4,780.42万
市值:29.22亿
市盈率:-185.72
高:23.68
开:21.90
低:21.84
收:21.33
52周最高:31.77
52周最低:11.86
股本:1.24亿
流通股本:8,824.23万
量比:1.94
换手率:2.34%
股息:- -
股息率:- -
每股收益(TTM):-0.1269
每股收益(LYR):-0.1269
净资产收益率:-9.30%
总资产收益率:-1.95%
市净率:15.42
市盈率(LYR):-185.72

数据加载中...

2024/05/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/03/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/04

重要事件披露

Form 8-K - Current report
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals